These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2883173)

  • 61. Models of anxiety.
    File SE
    Br J Clin Pract Suppl; 1985 May; 38():15-20. PubMed ID: 2862904
    [No Abstract]   [Full Text] [Related]  

  • 62. Neuroendocrine effects of buspirone in patients with generalized anxiety disorder.
    Cohn JB; Wilcox CS; Meltzer HY
    Am J Med; 1986 Mar; 80(3B):36-40. PubMed ID: 3963033
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone.
    Rickels K; Schweizer E; Csanalosi I; Case WG; Chung H
    Arch Gen Psychiatry; 1988 May; 45(5):444-50. PubMed ID: 2895993
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Can buspirone substitute for benzodiazepines in all anxious patients?
    Wang RI; Tiuseco D; Roh BL; Cho JK; Kochar C
    NIDA Res Monogr; 1989; 95():433-4. PubMed ID: 2577045
    [No Abstract]   [Full Text] [Related]  

  • 65. Anxiety: the pharmacological and sociological interface. Proceedings of a symposium. Englefield Green, Surrey, 29 November-1 December, 1984.
    Br J Clin Pract Suppl; 1985 May; 38():1-107. PubMed ID: 2862902
    [No Abstract]   [Full Text] [Related]  

  • 66. Female sexual dysfunction and antidepressant use.
    Terao T
    Am J Psychiatry; 2001 Feb; 158(2):326-7. PubMed ID: 11156829
    [No Abstract]   [Full Text] [Related]  

  • 67. Impact of anxiety therapy on patients' quality of life.
    Feighner JP
    Am J Med; 1987 May; 82(5A):14-9. PubMed ID: 2884872
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone).
    Tollefson GD; Montague-Clouse J; Tollefson SL
    J Clin Psychopharmacol; 1992 Feb; 12(1):19-26. PubMed ID: 1552035
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sexual dysfunction with psychotropic drugs.
    Gitlin M
    Expert Opin Pharmacother; 2003 Dec; 4(12):2259-69. PubMed ID: 14640925
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Establishing the maximum tolerated dose of lesopitron in patients with generalized anxiety disorder: a bridging study.
    Sramek JJ; Fresquet A; Marion-Landais G; Hourani J; Jhee SS; Martinez L; Jensen CM; Bolles K; Carrington AT; Cutler NR
    J Clin Psychopharmacol; 1996 Dec; 16(6):454-8. PubMed ID: 8959472
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lactose in buspirone.
    Pao M
    J Am Acad Child Adolesc Psychiatry; 1999 Nov; 38(11):1327. PubMed ID: 10560214
    [No Abstract]   [Full Text] [Related]  

  • 72. Buspirone: Back to the Future.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2015 Nov; 53(11):21-4. PubMed ID: 26535760
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons.
    Ratey JJ; Sovner R; Mikkelsen E; Chmielinski HE
    J Clin Psychiatry; 1989 Oct; 50(10):382-4. PubMed ID: 2793836
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Buspirone for the Treatment of Generalized Anxiety Disorder in Williams Syndrome: A Case Series.
    Thom RP; Keary CJ; Waxler JL; Pober BR; McDougle CJ
    J Autism Dev Disord; 2020 Feb; 50(2):676-682. PubMed ID: 31724120
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MDR1 in paroxetine-induced sexual dysfunction.
    Zourková A; Slanař O; Jarkovský J; Palčíková I; Pindurová E; Cvanová M
    J Sex Marital Ther; 2013; 39(1):71-8. PubMed ID: 23152970
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of generalized anxiety disorder and trichotillomania with buspirone.
    Reid TL
    Am J Psychiatry; 1992 Apr; 149(4):573-4. PubMed ID: 1554051
    [No Abstract]   [Full Text] [Related]  

  • 77. Symptom comorbidity in anxiety and depressive disorders.
    Copp JE; Schwiderski UE; Robinson DS
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):52S-60S. PubMed ID: 1973940
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical studies of "specific" anxiolytics as therapeutic agents.
    Rickels K
    Psychopharmacol Ser; 1987; 3():88-95. PubMed ID: 2881295
    [No Abstract]   [Full Text] [Related]  

  • 79. Efficacy of buspirone in alcohol dependence: a review.
    Malec TS; Malec EA; Dongier M
    Alcohol Clin Exp Res; 1996 Aug; 20(5):853-8. PubMed ID: 8865960
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Buspirone: a new type of anxiolytic.
    Dommisse CS; DeVane CL
    Drug Intell Clin Pharm; 1985 Sep; 19(9):624-8. PubMed ID: 2864225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.